Package 69097-248-03

Brand: darunavir 600 and 800 mg

Generic: darunavir
NDC Package

Package Facts

Identity

Package NDC 69097-248-03
Digits Only 6909724803
Product NDC 69097-248
Product ID 69097-248_e3d4803e-30b2-4c8b-90e3-b04c2da4b1c9
Description

60 TABLET in 1 BOTTLE (69097-248-03)

Marketing

Marketing Status
Marketed Since 2023-11-29
Brand darunavir 600 and 800 mg
Generic darunavir
Sample Package No

Linked Drug Pages (1)

Darunavir 600 and 800 mg ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e3d4803e-30b2-4c8b-90e3-b04c2da4b1c9", "openfda": {"upc": ["0369097248031", "0369097244026"], "unii": ["KPC4NRB25L"], "rxcui": ["670026", "1359269"], "spl_set_id": ["5624cc30-d484-458e-b234-9bb745a118ca"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (69097-248-03)", "package_ndc": "69097-248-03", "marketing_start_date": "20231129"}], "brand_name": "Darunavir 600 and 800 mg", "product_id": "69097-248_e3d4803e-30b2-4c8b-90e3-b04c2da4b1c9", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Protease Inhibitor [EPC]"], "product_ndc": "69097-248", "generic_name": "darunavir", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Darunavir 600 and 800 mg", "active_ingredients": [{"name": "DARUNAVIR HYDRATE", "strength": "600 mg/1"}], "application_number": "ANDA206288", "marketing_category": "ANDA", "marketing_start_date": "20231129", "listing_expiration_date": "20261231"}